BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15742330)

  • 21. Biologic factors associated with tumor oxygenation are prognostic in patients with stage III esophageal cancer: long-term results.
    Rades D; Bajrovic A; Schild SE; Thorns C; Kilic E
    Anticancer Res; 2014 Aug; 34(8):4351-5. PubMed ID: 25075070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer.
    Zenda S; Hironaka S; Boku N; Yamazaki K; Yasui H; Fukutomi A; Yoshino T; Onozawa Y; Nishimura T
    Dis Esophagus; 2008; 21(3):195-200. PubMed ID: 18430098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotherapy for small cell carcinoma of the esophagus: outcomes and prognostic factors from a retrospective study.
    Chen B; Yang H; Ma H; Li Q; Qiu B; Hu Y; Zhu Y
    Radiat Oncol; 2019 Nov; 14(1):210. PubMed ID: 31752922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone.
    Chua DT; Sham JS; Choy DT
    Cancer; 2004 Jul; 101(2):307-16. PubMed ID: 15241828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy.
    Rades D; Fehlauer F; Wroblesky J; Albers D; Schild SE; Schmidt R
    Oral Oncol; 2007 Jul; 43(6):535-43. PubMed ID: 17005437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective evaluation of combined modality treatment and prognostic factors in patients with esophageal cancer.
    Neuhof D; Neumayer F; Einbeck W; Haschemian K; Mai SK; Hochhaus A; Willeke F; Rudi J; Debus J; Wenz F
    Acta Oncol; 2005; 44(2):168-73. PubMed ID: 15788297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic implications of hemoglobin levels before and after surgery as well as before and after radiochemotherapy for head and neck tumors.
    Reichel O; Panzer M; Wimmer C; Dühmke E; Kastenbauer E; Suckfüll M
    Eur Arch Otorhinolaryngol; 2003 May; 260(5):248-53. PubMed ID: 12750913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgery versus radiotherapy for limited-stage small cell esophageal carcinoma: a multicenter, retrospective, cohort study in China (ChiSCEC).
    Zhu J; Wang Y; Sun H; Zhang Y; Zhang W; Shen W; Yang N; Tan B; Su X; Li L; Dong W; Ma J; Zhang J; Zhao L; Sun D; Yang P; Peng L; Li B; Huang W; Wang Q; Liao Z
    Int J Surg; 2024 Feb; 110(2):956-964. PubMed ID: 37995095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience.
    Wang S; Liao Z; Chen Y; Chang JY; Jeter M; Guerrero T; Ajani J; Phan A; Swisher S; Allen P; Cox JD; Komaki R
    J Thorac Oncol; 2006 Mar; 1(3):252-9. PubMed ID: 17409865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
    Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K
    Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a predictive factor for distant metastasis in esophageal squamous cell carcinoma after definitive chemoradiotherapy.
    Sakanaka K; Ishida Y; Itasaka S; Ezoe Y; Aoyama I; Miyamoto S; Horimatsu T; Muto M; Hiraoka M
    Int J Clin Oncol; 2016 Oct; 21(5):899-908. PubMed ID: 26936851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Factors affecting on long-time survival in patients with stage Ⅲ thoracic esophageal carcinoma after esophagectomy].
    Yang Q; Wang YX; He M; Li J; Qi Z; Zhu SC; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):530-7. PubMed ID: 27531268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of low hemoglobin levels on outcomes of radiotherapy following microscopically complete resection of locally advanced SCCHN: Implications for the future.
    Rades D; Seidl D; Janssen S; Wollenberg B; Hakim SG; Schild SE
    J Craniomaxillofac Surg; 2016 Sep; 44(9):1441-4. PubMed ID: 27470216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impact of pre-radiotherapy hemoglobin level on local control of nasopharyngeal carcinoma].
    Mai HQ; Mo HY; Hong MH; Guo X; Deng MQ; Zhang F; Min HQ
    Ai Zheng; 2005 Jun; 24(6):727-30. PubMed ID: 15946489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Definitive chemo-radiotherapy for squamous cell carcinoma of the pharynx: impact of baseline low hemoglobin level (<12 g/dL) and post-radiation therapy F-18 FDG-PET/CT.
    Katahira-Suzuki R; Hata M; Tateishi U; Taguchi T; Takano S; Omura-Minamisawa M; Inoue T
    Ann Nucl Med; 2015 Jan; 29(1):37-45. PubMed ID: 25228378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of haemoglobin level with morbidity and mortality of patients with locally advanced oesophageal carcinoma undergoing radiotherapy--a secondary analysis of three consecutive clinical phase III trials.
    Zhao KL; Liu G; Jiang GL; Wang Y; Zhong LJ; Wang Y; Yao WQ; Guo XM; Wu GD; Zhu LX; Shi XH
    Clin Oncol (R Coll Radiol); 2006 Oct; 18(8):621-7. PubMed ID: 17051953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy.
    Rades D; Stoehr M; Kazic N; Hakim SG; Walz A; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1108-14. PubMed ID: 17905528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.
    Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
    Xu X; Wang Z; Jiang S; Shang Y; Wu Y
    Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.